Results 101 to 110 of about 12,580 (199)

Effect of low and high dose of favipiravir on ovarian and reproductive function in female rats: Biochemical and histopathological evaluation

open access: yes, 2022
© The Authors 2022.Favipiravir is a drug which shows antiviral activity by inhibiting RNA-dependent RNA polymerase. Favipiravir causes severe adverse effects at high doses.
SÜLEYMAN, HALİS   +6 more
core   +1 more source

Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev)

open access: yesJournal of Virus Eradication
Background: While certain studies have demonstrated that antiviral treatment administered to index patients with influenza can mitigate the transmission within households, the efficacy of anti-SARS-CoV-2 agents in curtailing household transmission ...
Taweegrit Siripongboonsitti   +10 more
doaj   +1 more source

Risk of Bias-Favipiravir for covid-19

open access: yes
Favipiravir for covid ...
pritish korula (17822568)   +6 more
core   +1 more source

Discovery of novel favipiravir derivatives with improved pharmacokinetic properties as anti-SFTSV agents

open access: yesEuropean Journal of Medicinal Chemistry Reports
Favipiravir is a nucleobase analogue that exhibits antiviral activities against a variety of RNA viruses. Due to the lack of antivirals to combat SFTS, an emerging tickborne epidemic caused by a RNA virus belonging to the Phenuividae family within ...
Xiaomeng He   +7 more
doaj   +1 more source

A RETROSPECTIVE ANALYSIS OF REPURPOSED THERAPEUTICS USED DURING THE DELTA VARIANT INDUCED COVID-19 CRISIS OF INDIA, 2021

open access: yesМедицина в Кузбассе, 2023
COVID-19 has led to a major worldwide health and economic crisis, with more than 27 million people having contracted the disease and more than 800 000 deaths.
Srinivasa Jayachandra   +4 more
doaj  

Experimental Studies on Some Drugs Used in Covid-19 Treatment (Favipiravir and Dexamethasone) in Albino Rats

open access: yes, 2023
In this study, the side effects of some anti-covid-19 drugs (Favipiravir and Dexamethasone) were evaluated through the pathological, and clinicopathological changes in the tissues of rats.
El-Seddawy, Nora M.   +3 more
core  

ICU admission and favipiravir

open access: yesNorthern Clinics of Istanbul, 2021
Mungmunpuntipantip, Rujittika   +1 more
openaire   +2 more sources

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

open access: yesBMC Infectious Diseases
Brief summary In early symptomatic COVID-19 treatment, high dose oral favipiravir did not accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral activity against SARS-CoV-2.
Viravarn Luvira   +35 more
doaj   +1 more source

Dose-Dependent Pulmonotoxic Effects of Favipiravir in Rats Biochemical and Histopathological Evaluation

open access: yes
Background and Objective: Favipiravir is associated with more serious side effects at higher doses. This experimental study proposed to investigate the effect of favipiravir on dose-dependent lung toxicity in rats biochemically and histopathologically ...
Suleyman, Halis   +4 more
core   +1 more source

Cost-Effectiveness Analysis of Favipiravir and Remdesivir as COVID-19 Treatment in South Tangerang, Banten Province - Indonesia

open access: yesPharmacology and Clinical Pharmacy Research
COVID-19 is a contagious ailment primarily attributed to the severe acute respiratory syndrome coronavirus. Indonesia persists in confronting the COVID-19 pandemic, and South Tangerang City has emerged as one of the municipalities in Indonesia that has ...
Wahyu G. Putro   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy